Autocoids in Hypertension: Pathogenesis and End Organ Damage
Autocoids in Hypertension: Pathogenesis and End Organ Damage
批准号:
9212642
负责人:
Pablo A. Ortiz
金额:
$247.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1982
资助国家:
美国
项目状态:
已结题
起止时间:
1982-09-01 至 2019-01-31
关键词:
Angiotensin-Converting Enzyme InhibitorsAngiotensinsAnimalsAnti-DNA AntibodiesAnti-Inflammatory AgentsAnti-inflammatoryArachidonic AcidsArtsAutoimmune DiseasesAutoimmune ProcessB-LymphocytesBiometryBlood PressureCardiacCardiovascular DiseasesCellsCollaborationsComplexCytokine ActivationDahl Hypertensive RatsDataDevelopmentDiabetes MellitusDilatation - actionDinoprostoneDiseaseDistalEP4 receptorEicosanoidsEnd stage renal failureEndocrineEndocrine systemEquilibriumExcretory functionFeedbackFractalkineGenerationsGlomerular CapillaryGraft RejectionHeart failureHydrolysisHypertensionImmune systemImmunosuppressionIncidenceInflammationInflammatoryInstructionKidneyKidney DiseasesKininsKnockout MiceKnowledge acquisitionLeadLimb structureLys-AspMediatingMediationMedicalMicrocirculationModelingMolecularMorphologyMusMutant Strains MiceMyocardial InfarctionMyocarditisNF-kappa BNamesNatriuresisNatural ImmunityNephronsNitric OxideOrganPTGS2 genePathogenesisPharmacologyPhysiologicalPlayPopulationProcessProductionProstaglandinsRattusReactive Oxygen SpeciesReceptor SignalingRegulationRegulatory T-LymphocyteRenal functionRenin-Angiotensin SystemReportingResearchResearch PersonnelRoleSodiumSodium ChlorideSystemSystemic Lupus ErythematosusT-LymphocyteTestingTherapeutic EffectThickTransgenic OrganismsWFDC2 geneWaterabsorptionadaptive immunityarterioleautocrineblood pressure regulationcardiovascular risk factorchemokinechronic autoimmune diseaseconnective tissue growth factorcyclooxygenase 2cytokinehypertension treatmentimmune activationimprovedknockout genelysylprolinemortalitymouse modelnormotensivenovelnovel therapeutic interventionparacrinepressurepreventreceptorresponsesalt intakesalt sensitive hypertensionsensortreatment strategyurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
This PPG was started in September, 1982. The central theme is "the study ofthe role of vasoactive systems (autocrine, juxtacrine, paracrine and endocrine) in the regulation of renal function and blood pressure (BP) and mediation of end organ damage (EOD)". The general hypothesis to be tested is that there is a balance between systems that promote water and sodium retention, hypertension and EOD, including Angiotensin II (Ang II), prostanoids, reactive oxygen species and inflammation, and systems that antagonize these effects like Ac-SDKP, activation of the Ang II type 2 receptor (AT2), kinins, NO, PGE2/EP4, and the newly discovered cross-talk between the connecting tubule and the afferent arteriole (CTGF) which may participate in both natriuresis and renal damage. Alterations of this balance in favor of the former are responsible for retention of water and sodium and development of hypertension and EOD, while alterations of this balance in favor of the latter have therapeutic effects. We will use
molecular, physiological, and pharmacological approaches' to study vasoactive systems at the subcellular, cellular, and isolated organ levels in hypertension in rats and various transgenic and
gene knockout mice. We will mainly use Dahl salt-sensitive rats (Dahl SS) and Ang ll-induced hypertensive rats as models. In Project I, using Dahl SS rats, we will study whether N-acetyl-seryl-aspartyl-lysyl-proline protects against EOD by decreasing adaptive immunity. In Project II we will study whether expression of cyclooxygenase-2 and generation of PGE2 via the EP4 receptor protects against EOD in Ang ll-induced hypertension. In Project III, using Dahl SS rats, we will study whether CTGF causes glomerular damage via afferent arterole dilatation and increases in capillary glomerular pressure. In Project IV, using Dahl SS rats, we will study whether a decrease in the renal thick ascending limb AT2-signaling participates in the pathogenesis of hypertension. Four cores. Administrative (A), Analytical and Morphological (B), Mutant Mouse (C), and Biostatistics (D) will support the scientific efforts of the investigators. Te PPG provides integration of our efforts, collaboration, sharing of ideas and expertise, thus accelerating acquisition of knowledge on the causes of hypertension and EOD.
期刊论文(321)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/s0895-7061(98)00235-0
发表时间:
1999-02
期刊:
American journal of hypertension
影响因子:
3.2
作者:
[Ding Wang;Xiao-Ping Yang;Yun-he Liu;Oscar A. Carretero;M. Lapointe]
通讯作者:
Ding Wang;Xiao-Ping Yang;Yun-he Liu;Oscar A. Carretero;M. Lapointe
DOI:
10.1161/01.hyp.30.3.735
发表时间:
1997-09
期刊:
Hypertension
影响因子:
8.3
作者:
[X. P. Yang;Yun-he Liu;G. Scicli;C. Webb;O. Carretero]
通讯作者:
X. P. Yang;Yun-he Liu;G. Scicli;C. Webb;O. Carretero
DOI:
10.1161/hypertensionaha.113.01164
发表时间:
2013-07
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Ren Y, D'Ambrosio MA, Garvin JL, Wang H, Carretero OA]
通讯作者:
Carretero OA
DOI:
10.1111/j.1523-1755.2005.00282.x
发表时间:
2005-05
期刊:
Kidney international
影响因子:
19.6
作者:
[Ruisheng Liu;O. Carretero;Yilin Ren;J. Garvin]
通讯作者:
Ruisheng Liu;O. Carretero;Yilin Ren;J. Garvin
DOI:
10.1161/hypertensionaha.111.173344
发表时间:
2011-08
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Gironacci MM, Adamo HP, Corradi G, Santos RA, Ortiz P, Carretero OA]
通讯作者:
Carretero OA
共 187 条
Regulation of NKCC2 and renal NaCl transport by protein-protein interactions
-
批准号:10585141
-
项目类别:
-
资助金额:$60.22万
-
财政年份:2023
-
负责人:Pablo A. Ortiz
-
依托单位:
Regulation of NKCC2 and renal NaCl transport by protein-protein interactions
-
批准号:10476068
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2021
-
负责人:Pablo A. Ortiz
-
依托单位:
Fructose induced salt-sensitive hypertension: Role of thick ascending limb transport
-
批准号:9128235
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2016
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt-sensitive Hypertension and the Thick Ascending Limb
-
批准号:8376982
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2012
-
负责人:Pablo A. Ortiz
-
依托单位:
Administrative Core
-
批准号:8376987
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2012
-
负责人:Pablo A. Ortiz
-
依托单位:
Imaging Core
-
批准号:8376990
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2012
-
负责人:Pablo A. Ortiz
-
依托单位:
Imaging Core
-
批准号:7595346
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2009
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt-sensitive Hypertension and the Thick Ascending Limb
-
批准号:7595339
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2009
-
负责人:Pablo A. Ortiz
-
依托单位:
Blood Pressure Regulation: Novel Roles for the Kidney
-
批准号:8235821
-
项目类别:
-
资助金额:$205.44万
-
财政年份:2009
-
负责人:Pablo A. Ortiz
-
依托单位:
Blood Pressure Regulation: Novel Roles for the Kidney
-
批准号:8448082
-
项目类别:
-
资助金额:$195.58万
-
财政年份:2009
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt Absorption by the THAL: Role of NKCC2 trafficking
-
批准号:7038025
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2006
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt Absorption by the THAL: Role of NKCC2 trafficking
-
批准号:7735576
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2006
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt Absorption by the THAL: Role of NKCC2 trafficking
-
批准号:7178527
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2006
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt Absorption by the THAL: Role of NKCC2 trafficking
-
批准号:7544501
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2006
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt Absorption by the THAL: Role of NKCC2 trafficking
-
批准号:7326831
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2006
-
负责人:Pablo A. Ortiz
-
依托单位:
Imaging Core
-
批准号:8055477
-
项目类别:
-
资助金额:$18.22万
-
财政年份:--
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt-sensitive Hypertension and the Thick Ascending Limb
-
批准号:8448086
-
项目类别:
-
资助金额:$29.62万
-
财政年份:--
-
负责人:Pablo A. Ortiz
-
依托单位:
Imaging Core
-
批准号:8235820
-
项目类别:
-
资助金额:$18.22万
-
财政年份:--
-
负责人:Pablo A. Ortiz
-
依托单位:
Imaging Core
-
批准号:8448097
-
项目类别:
-
资助金额:$17.34万
-
财政年份:--
-
负责人:Pablo A. Ortiz
-
依托单位:
Salt-sensitive Hypertension and the Thick Ascending Limb
-
批准号:8055472
-
项目类别:
-
资助金额:$31.11万
-
财政年份:--
-
负责人:Pablo A. Ortiz
-
依托单位:
海外基金